How has Tectonic Therapeutics's operating lease liabilities changed year-over-year?

Tectonic Therapeutics's operating lease liabilities increased by 73.4% year-over-year, from -$553K to -$147K.

Tectonic Therapeutics TECX Operating lease liabilities

Operating lease liabilities at other companies

Septerna, Inc.SEPN

——

Ginkgo BioworksDNA

——

Rigel PharmaceuticalsRIGL

——

Ethos Technologies, Inc. LIFE

——

PrecigenPGEN

——

Apogee Therapeutics, Inc.APGE

——

Other financials

Income statement

See full

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Balance sheet

See full

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Cash flow

See full

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Valuation

See full

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Returns & leverage

See full

Return on equity-31.4%—

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tectonic Therapeutics's operating lease liabilities?: Tectonic Therapeutics (TECX) reported operating lease liabilities of -$147K in Q1 2026.
How has Tectonic Therapeutics's operating lease liabilities changed year-over-year?: Tectonic Therapeutics's operating lease liabilities increased by 73.4% year-over-year, from -$553K to -$147K.